Bjørn Olav Å.
- Country
- Norway
- Department
- Department of Medicine
Research Overview
- Evaluation of Metyrapone in Patients with Mild Autonomous Cortisol Secretion: A 6-Month Clinical Trial Assessing Hypertension, Glucose Metabolism, and Cortisol Levels
- Randomized, Open-Label Study on Health-Related Quality of Life in Primary Adrenal Insufficiency: Comparison of Hydrocortisone (Plenadren) and Cortisone Therapy
Data & Insights
Has run more than one trial at 4 of 14 partner sites.
Specializations
Endocrine Disorders
The investigator specializes in the management of primary adrenal insufficiency (PAI) and related endocrine conditions, with particular attention to cortisol-related disorders.
- Adrenal Insufficiency Management
- Cortisol Regulation
- Hormone Replacement Therapy
Studies focus on optimizing treatment approaches for patients with adrenal disorders.
Metabolic Health
Research interests extend to metabolic complications associated with mild autonomous cortisol secretion, examining the interconnections between hormonal imbalances and metabolic health.
- Hypertension Management
- Glucose Metabolism
- Cortisol Level Assessment
Investigates therapeutic interventions for improving metabolic parameters in patients with hormonal disorders.
Quality of Life Assessment
Dedicated to evaluating health-related quality of life (HRQoL) outcomes in patients with endocrine disorders, particularly focusing on comparative treatment effectiveness.
- Treatment Optimization
- Patient Outcomes Assessment
- Long-term Health Monitoring
Explores the impact of various treatment modalities on patient wellbeing and daily functioning.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.